Evidence map›Paper›PMID 38087230›Full record

ArticleBMC complementary medicine and therapies2023

Medicinal plants used in the management of cancers by residents in the Elgon Sub-Region, Uganda.

Ali Kudamba, Josephine N Kasolo, Godfrey S Bbosa, Allan Lugaajju, Henry Wabinga, Nixon Niyonzima, Moses Ocan, Ali M Damani, Hussein M Kafeero, Jamilu E Ssenku and 4 more

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in pharmacology · 2025
    Article
  7. Review
  8. Unlocking the therapeutic mechanism ofFrontiers in pharmacology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ali KudambaDepartment of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda. alikudamba@gmail.com.
Josephine N KasoloDepartment of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Godfrey S BbosaDepartment of Pharmacology & Therapeutics, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Allan LugaajjuDepartment of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Henry WabingaDepartment of Pathology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Nixon NiyonzimaUganda Cancer Institute, Kampala, Uganda.
Moses OcanDepartment of Pharmacology & Therapeutics, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Ali M DamaniDepartment of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Hussein M KafeeroFaculty of Health Sciences, Habib Medical School, Islamic University in Uganda, Kampala, Uganda.
Jamilu E SsenkuFaculty of Science, Department of Biological Sciences, Islamic University in Uganda, Mbale, Uganda.
Shaban O AlemuFaculty of Science, Department of Biological Sciences, Islamic University in Uganda, Mbale, Uganda.
Muhammad LubowaFaculty of Science, Department of Food Science & Nutrition, Islamic University in Uganda, Mbale, Uganda.
Abdul WalusansaFaculty of Health Sciences, Habib Medical School, Islamic University in Uganda, Kampala, Uganda.
Haruna MuwongeDepartment of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.

Funding

Makerere University funded by Republic of Uganda through Makerere University Research & Innovation Fund (Makrif) MAK-RIF/IND-RD2/2174
6 · The paper itself

Abstract

backgroundIn Uganda, medicinal plants have been utilized to treat a variety of ailments, including cancer. However, there is little information available about the medicinal plants used to treat cancer in the Elgon subregion. As a result, the current study documented the plant species used in the management of cancer in the Elgon sub-region.

methodsData were gathered by observation, self-administered questionnaires, interview guides, and guided field trips. Analyzing descriptive statistics and creating graphs were done using SPSS (version 21.0) and GraphPad Prism® version 9.0.0, respectively. Well-established formulae were used to calculate quantitative indices. The narratives were interpreted using major theories and hypotheses in ethnobotany.

resultsA total of 50 plant species from 36 families were documented, and herbal knowledge was mainly acquired through inheritance. Fabaceae and Asteraceae comprised more plant species used in herbal preparation. Most plants were collected from forest reserves (63%); herbal therapies were made from herbs (45%); and leaves were primarily decocted (43%). The most frequently used plants were Tylosema fassoglensis, Hydnora abyssinica, Azidarachata indica, Prunus Africana, Kigelia africana, Syzygium cumini, Hydnora africana, Rhoicissus tridentata, Albizia coriaria, and Plectranthus cuanneus. All the most commonly used plants exhibited a high preference ranking (60-86%) and reliability level (74.1-93.9%). Generally, the ICF for all the cancers treated by medicinal plants was close to 1 (0.84-0.95).

conclusionsThe ten most commonly utilized plants were favored, dependable, and most important for treating all known cancers. As a result, more investigation is required to determine their phytochemistry, toxicity, and effectiveness in both in vivo and in vitro studies. This could be a cornerstone for the pharmaceutical sector to develop new anticancer medications.

Indexed as

NeoplasmsPlants, MedicinalHealth Knowledge, Attitudes, PracticeHumansMedicine, African TraditionalReproducibility of ResultsUgandaCancerElgon sub-regionEthnobotanical surveyHerbalistsMedicinal plants

Identifiers

PMID38087230
PMCPMC10714536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.